These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6356852)

  • 1. Autonomic, systemic, and renal hemodynamic actions of trimazosin in hypertensive patients.
    Chrysant SG
    Am Heart J; 1983 Nov; 106(5 Pt 2):1243-50. PubMed ID: 6356852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of trimazosin: an effective and safe antihypertensive agent.
    Taylor CR; Leader JP; Singleton W; Munster EW; Falkner FC; O'Neil JA
    Am Heart J; 1983 Nov; 106(5 Pt 2):1269-81. PubMed ID: 6227228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical hemodynamic profile of trimazosin in hypertension.
    Pool PE; Seagren SC; Salel AF
    Am Heart J; 1983 Nov; 106(5 Pt 2):1237-42. PubMed ID: 6356851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of trimazosin and propranolol in essential hypertension.
    Helgeland A
    Am Heart J; 1983 Nov; 106(5 Pt 2):1253-8. PubMed ID: 6356854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term haemodynamic effects of sustained-release trimazosin at rest and during exercise in essential hypertension.
    Omvik P; Lund-Johansen P
    Eur J Clin Pharmacol; 1991; 40(2):131-4. PubMed ID: 2065694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and renal hemodynamic effects of trimazosin: a new vasodilator.
    Chrysant SG; Luu TM; Danisa K; Kem DC; Manion CV
    J Cardiovasc Pharmacol; 1980; 2(2):205-14. PubMed ID: 6171687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind study of trimazosin and methyldopa in hypertensive patients receiving polythiazide.
    Moyer RR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1250-3. PubMed ID: 6356853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of trimazosin on serum lipid profiles in hypertensive patients.
    Singleton W; Taylor CR
    Am Heart J; 1983 Nov; 106(5 Pt 2):1265-8. PubMed ID: 6356856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimazosin for the treatment of hypertensive patients failing to respond to thiazides.
    Oberman A; Pool PE
    Am Heart J; 1983 Nov; 106(5 Pt 2):1258-64. PubMed ID: 6356855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of atenolol and long-acting trimazosin in mild to moderate essential hypertension.
    Webb DJ; Hutcheson MJ; Robertson MP; Murray GD; Lorimer AR; Robertson JI
    Scott Med J; 1985 Apr; 30(2):106-10. PubMed ID: 3892676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of trimazosin and its effects on blood pressure, renal function and proteinuria during short-term therapy of patients with impaired renal function and hypertension.
    van Kalken CK; van der Meulen J; Oe PL; Vriesendorp R; Donker AJ
    Eur J Clin Pharmacol; 1986; 31(1):63-8. PubMed ID: 3780829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vasodilator that avoids renin stimulation and fluid retention: antihypertensive treatment with trimazosin.
    Weber MA; Brewer DD; Drayer JI; Aronow WS; Lipson JL; Ricci BA
    Clin Pharmacol Ther; 1982 May; 31(5):572-8. PubMed ID: 7042174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a sustained-release formulation of trimazosin in mild to moderate hypertension.
    Byyny RL; Nies AS; LoVerde ME; Mitchell WD
    J Clin Pharmacol; 1987 Feb; 27(2):101-5. PubMed ID: 3680560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension.
    Sampieri L; Cuspidi C; Boselli L; Angioni L; Castiglioni G; Zanchetti A; Mancia G
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):535-42. PubMed ID: 2908716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of trimazosin on hemodynamics in chronic heart failure.
    Orlando JR; Danahy DT; Lurie M; Aronow WS
    Clin Pharmacol Ther; 1978 Nov; 24(5):531-6. PubMed ID: 359215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term hemodynamic and metabolic effects of trimazosin in essential hypertension.
    Chrysant SG; Miller RF; Brown JL; Danisa K
    Clin Pharmacol Ther; 1981 Nov; 30(5):600-4. PubMed ID: 7028356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rest and exercise hemodynamic effects of sequential alpha-1-adrenoceptor (trimazosin) and beta-adrenoceptor (propranolol) antagonism in essential hypertension.
    Nelson GI; Silke B; Hussain M; Verma SP; Taylor SH
    Am Heart J; 1984 Jul; 108(1):124-31. PubMed ID: 6731261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute responses to urapidil in hypertensive persons.
    de Leeuw PW; Birkenhäger WH
    Am J Cardiol; 1989 Aug; 64(7):22D-24D. PubMed ID: 2667310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.